Back to News
Mergers & Acquisitions

The Deal Awards 2021: Winners Revealed

By The Deal Staff
|
Published: September 24th, 2021
The Deal honored the top dealmakers across a range of deal sizes, sectors and specialties for their exemplary work on various M&A transactions.

The Deal on Thursday, Sept. 23, announced the winners of its fourth annual Deal Awards program, honoring the top dealmakers in sector specialties as well as areas of dealmaking including restructuring, activism and private equity.

The 2021 Deal Awards honored deals and dealmakers for their work on transactions announced, completed or in flux during 2020. The Deal research team combed through thousands of transactions and hundreds of nominations to decide the top advisers and identify the deals that exemplified the biggest trends of the year.

For this year’s awards The Deal combined the middle market and more traditional large-cap New York ceremony into one live event, hosted at the JW Marriott Essex House in Manhattan.

Among the notable winners — the full list of which is available on our events page — T-Mobile US Inc.’s (TMUS) $26 billion megamerger with Sprint Corp. took home Deal of the Year in the large-cap category while a deal from Fox Corp. (FOX) to acquire Tubi Inc. took home our Deal of the Year in the middle market. SoftBank Group Corp.’s monetization of its stake in the combined T-Mobile entity was the Most Innovative Large-Cap Deal of the Year.

Sidley Austin LLP took home the Activist Defense Law Firm of the Year award while Kirkland & Ellis LLP and Cole Schotz PC were Debtor Counsel of the Year in the large-cap and middle-market segments, respectively.

On the dealmaker front, Kris S. Withrow, co-chair of Fenwick & West LLP’s M&A group, won middle-market Dealmaker of the Year, as well as middle-market TMT Dealmaker of the Year. Andrew J. Nussbaum of Wachtell, Lipton, Rosen & Katz took home large-cap Dealmaker of the Year.

Check out the complete list of categories and winners on our events page.

More From Mergers & Acquisitions

Mergers & Acquisitions

Drinks With The Deal: Krishna Veeraraghavan of Paul Weiss

By David Marcus
|
Published: October 14th, 2021
M&A lawyer Krishna Veeraraghavan talked about healthcare dealmaking and the risks of excessive antitrust regulation of combinations between biotech and pharma companies in the Drinks With The Deal podcast.
Mergers & Acquisitions

OpEd: ESG in Due Diligence Is Not Just Another Box to Check

By Deal Contributors
|
Published: October 5th, 2021
With ESG now a day-to-day focus for management and directors across industries, companies would be well-served to undertake a thoughtful assessment of ESG risks when evaluating potential targets in M&A activities.
Activism

CorpGov: Barshay Says Lina Khan Can't Sue Everybody

By Tom Terrarosa
|
Published: October 1st, 2021
The powerhouse corporate attorney handed out some advice to companies, ESG investors and the broader investment community at The Deal's Corporate Governance 2021 conference.